BIT
LPCN icon

BlackRock Institutional Trust’s Lipocine LPCN Stock Holding History

BlackRock Institutional Trust’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.35M Hold
21,521
– – ﹤0.01% 3195
2016
Q3 		$1.63M Hold
21,521
– – ﹤0.01% 3128
2016
Q2 		$1.11M Buy
21,521
+8,335
+63% +$1.29M ﹤0.01% 3273
2016
Q1 		$2.27M Buy
13,186
+147
+1% +$25.1K ﹤0.01% 2991
2015
Q4 		$2.87M Sell
13,039
-824
-6% -$173K ﹤0.01% 2963
2015
Q3 		$2.79M Buy
13,863
+13,748
+11,955% +$3.18M ﹤0.01% 2982
2015
Q2 		$17K Buy
+115
New +$14.3K ﹤0.01% 3850

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's LPCN Position: Q4 2016 in Review

BlackRock Institutional Trust held its Lipocine (LPCN) position steady in Q4 2016 at 21,521 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

BlackRock Institutional Trust first reported a position in LPCN in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.87M in Q4 2015. 58 funds tracked by Wall St. Rank hold LPCN as of Q4 2016.

  • BlackRock Institutional Trust held 21,521 shares of Lipocine worth $1.35M as of Q4 2016.
  • BlackRock Institutional Trust left its Lipocine share count unchanged in Q4 2016.
  • Lipocine made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3195 holding.
  • BlackRock Institutional Trust first reported a position in Lipocine in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Institutional Trust's Lipocine position peaked at $2.87M in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Lipocine as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.